Experienced regional head and GM. 15+ years in healthcare with leading brands including Eli Lilly, Boston Scientific, Baxter, GSK, Merck&Co.
Global leader with a cross cultural mindset. Significant Asia Pacific experience.
Advisor to startups and incubators in healthcare and technology in emerging high growth markets. Private investor in early stage and promising SMEs.
The Propell Group focuses on early-stage investments and startup acceleration globally within the healthcare technology sector.
We provide pragmatic mentorship from early stage to startups pitching for funding. We seed and/or provide access to funding for the most promising startups.
We support each startup with access to an extensive network of multinationals, investors and government agencies.
Direct Portfolio includes: Nurep, Rani Therapeutics, The Hideaways Club, Move Correctly, Innua Petrochem, CellCrypt, AHA!
Indirect Portfolio includes: Jana, Quality Time Labs, Chrono Health Care, VISCCO, OHM, ACM Biolabs, PlayMoolah
It also provide business strategy advisory to SMEs and larger organisations which seek to deliver innovative commercial solutions principally in Asia Pacific